Cargando…

Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis

BACKGROUND: Reported evidence of coronary stent fracture (CSF) has increased in recent years. The purpose of this study was to determine reliable estimates of the overall incidence of CSF. METHODS AND RESULTS: The MEDLINE, Embase and Cochrane databases were searched until March 18, 2022. Pooled esti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yang, Li, Dandan, Liao, Yanhui, Yao, Xiongda, Ruan, Yuehua, Zou, Kai, Liao, Hanhui, Ding, Jingwen, Qin, Hao, Yu, Zuozhong, Zhao, Yuanbin, Hu, Longlong, Yang, Renqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445981/ https://www.ncbi.nlm.nih.gov/pubmed/36082117 http://dx.doi.org/10.3389/fcvm.2022.925912

Ejemplares similares

Lipid metabolism patterns and relevant clinical and molecular features of coronary artery disease patients: an integrated bioinformatic analysis
por: Liao, Yanhui, et al.
Publicado: (2022)

Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction
por: Chen, Yang, et al.
Publicado: (2021)

New Insights into the Role of HMGB2 in ST-Segment Elevation Myocardial Infarction
por: Qin, Hao, et al.
Publicado: (2023)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Five-year comparative study of thin-strut rapamycin-eluting bioabsorbable scaffold with metallic drug-eluting stent in porcine coronary artery
por: Liu, Yaokun, et al.
Publicado: (2022)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Xi, Hongfei, et al.
Publicado: (2023)

Optical Coherence Tomography-guided Treatment of Multiple Stent Fracture in Patients with Overlapping Drug-eluting Stents
por: Lee, Jung-Hee, et al.
Publicado: (2018)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis
por: Qiao, Yanxiang, et al.
Publicado: (2013)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
por: Yuan, Haoyong, et al.
Publicado: (2022)

Fractured coronary stent with mycotic pseudoaneurysm and abscess
por: Kumar, Naveen, et al.
Publicado: (2022)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation
por: Kuramitsu, Shoichi, et al.
Publicado: (2014)

Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus
por: Wang, Hao-Yu, et al.
Publicado: (2020)

Three aneurysms developed in three different drug-eluting stents
por: Lee, Young-Soo, et al.
Publicado: (2009)

Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study
por: Li, Yang, et al.
Publicado: (2022)

Atrial fibrillation and breast cancer—Vicious twins? A systematic review and meta-analysis
por: Yao, Xiongda, et al.
Publicado: (2023)

Repair effect of the poly (D,L-lactic acid) nanoparticle containing tauroursodeoxycholic acid-eluting stents on endothelial injury after stent implantation
por: Zhou, Jiedong, et al.
Publicado: (2022)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Yong, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
por: Roh, Ji Woong, et al.
Publicado: (2022)

Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation
por: Yi, Ming, et al.
Publicado: (2022)

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
por: Cui, Kongyong, et al.
Publicado: (2021)

Longitudinal Stent-Strut Injury at the Distal End of a Newer-generation Drug-eluting Stent
por: Jin, Uram, et al.
Publicado: (2017)

In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Short-term outcomes of drug-coated balloon versus drug-eluting stent for de novo saphenous vein graft lesions in coronary heart disease
por: Lin, Li, et al.
Publicado: (2023)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
por: Cha, Jung-Joon, et al.
Publicado: (2022)

Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study
por: Wang, Xi, et al.
Publicado: (2023)

Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis — coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial
por: Kim, Chi-Hoon, et al.
Publicado: (2017)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Coronary stent on the move
por: Bews, Hilary, et al.
Publicado: (2021)

Coronary stent infection
por: Hulshof, Pim B J E, et al.
Publicado: (2021)

Intravascular Ultrasound-Guided Percutaneous Coronary Intervention with Drug-eluting Stent for Unprotected Left Main Disease via Left Snuffbox Approach
por: Kim, Yongcheol, et al.
Publicado: (2018)

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
por: Arat Ozkan, Alev, et al.
Publicado: (2016)

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials
por: Cai, Jin-Zan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c3t18ofc514a58jlhgkgo4bvvi